Rohto Pharmaceutical
4527.T
$25.90
Share price
-0.11%
Change (1 day)
-25.50%
Change (1 year)
Categories
Operating Margin for Rohto Pharmaceutical (4527.T)
Operating Margin as of March 2025 (TTM): 15.32%
According to Rohto Pharmaceutical's latest financial reports and stock price the company's current Operating Margin is 15.32%. At the end of 2024 the company had an Operating Margin of 15.40%.
Operating Margin history for Rohto Pharmaceutical from 2009 to 2024
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | 15.40% | 6.43% |
| 2023 | 14.47% | 2.73% |
| 2022 | 14.09% | 10.16% |
| 2021 | 12.79% | 10.21% |
| 2020 | 11.60% | 29.56% |
| 2019 | 8.96% | -9.31% |
| 2018 | 9.87% | 2.54% |
| 2017 | 9.63% | 10.79% |
| 2016 | 8.69% | -5.52% |
| 2015 | 9.20% | -10.23% |
| 2014 | 10.25% | -4.53% |
| 2013 | 10.73% | -9.68% |
| 2012 | 11.88% | -0.62% |
| 2011 | 11.96% | 6.21% |
| 2010 | 11.26% | 28.15% |
| 2009 | 8.79% | -26.62% |
| 2008 | 11.97% |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.